Big Move For Acurx Pharmaceuticals, Inc.
Wed, Oct 08, 2025 at 07:54 PM
Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ) shot up at $8.1, a gain of 89.3%. On Wed, Oct 08, 2025, ACXP:NASDAQ touched a New 2-Week High of $8.1. The stock appeared on our News Catalysts scanner on Tue, Sep 30, 2025 at 12:19 PM in the 'BIOTECH' category. From Wed, Sep 24, 2025, the stock recorded 60.00% Up Days and 63.64% Green Days
The stock spiked on Tue, Jun 17, 2025 at $21 with a volume of 17M+.
About Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ)
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health...
Top 10 Gainers:
- Xenetic Biosciences, Inc. (XBIO:NASDAQ), 141.49%
- Nexalin Technology, Inc. (NXL:NASDAQ), 98.25%
- AlphaTON Capital Corp Shs (New) (ATON:NASDAQ), 95.52%
- Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 89.25%
- Universe Pharmaceuticals INC (UPC:NASDAQ), 82.98%
- Adaptimmune Therapeutics plc (ADAP:NASDAQ), 51.88%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 46.43%
- TNL Mediagene (TNMG:NASDAQ), 45.5%
- Soluna Holdings, Inc. (SLNH:NASDAQ), 39.41%